Tradestie Institutional Equity Comparison Engine
NEXR vs CMND โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CMND Overall Edge
CMND Captures Institutional Edge (2โ0 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Clearmind Medicine Inc. Common Shares (CMND) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, NEXR trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CMND at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NEXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CMND sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
NEXR N/M vs CMND N/M Fwd P/E
Growth & Margin Winner
CMND
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
CMND
1Y -39.2% vs +1108.2% ยท 52W Pos 23% vs 58%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
NEXR
US Equity
NEXR
Institutional Equity
$1.38
-7.38% 1D
Market Cap
N/A
1M Return
+67.27%
1Y Return
-39.21%
Forward P/E
N/M
Unified AI Score
31.0 / 100
SELL
Tech 50.0
Fund 27.0
Flow 50.0
Mom 40.0
CMND
NASDAQ
Clearmind Medicine Inc. Common Shares
Pharmaceutical Preparations
$4.18
-7.67% 1D
Market Cap
$2.3M
1M Return
-33.18%
1Y Return
+1108.17%
Forward P/E
N/M
Unified AI Score
49.8 / 100
HOLD
Tech 40.0
Fund 48.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NEXR -39.21%
CMND +1108.17%
Spread: +341.39 pp (CMND Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NEXR TTM Op. Margin: N/A
CMND TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NEXR vs CMND. Trailing 12-month operating profitability (NEXR N/A vs CMND 0.0%) and valuation multiples (NEXR N/M vs CMND N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NEXR | CMND | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $2.3M | Larger Scale | CMND |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | CMND |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | CMND |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | CMND |
| Return on Equity (ROE) Capital Efficiency | N/A | -107.0% | Higher ROE | CMND |
| 52-Week Range Position Momentum | 23% ($0โ$5) | 58% ($0โ$7) | Stronger Trend | CMND |
| Beta / 30D Volatility Risk Regime | 8.42ฮฒ ยท 2730% Vol | 3.87ฮฒ ยท 58% Vol | Lower Realized Risk | CMND |
| Unified Institutional Score Composite Signal | 31.0 / 100 (SELL) | 49.8 / 100 (HOLD) | Higher Composite | CMND |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NEXR vs CMND Buy Guide
NEXR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CMND
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NEXR nor CMND registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.